Government backs reforms allowing patients access to cheaper life-saving drugs
Ministers have committed to finding new ways to ensure off-patent drugs could be prescribed to patients on the NHS
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Patients could get quicker access to low-cost, potentially life-saving drugs for conditions including breast cancer, Parkinson’s and multiple sclerosis, after the Government backed a cross-party reform plan.
Ministers have committed to finding new ways to ensure off-patent drugs could be prescribed to patients on the NHS, where evidence shows they could be beneficial.
Leading charity Breast Cancer Now said it was “encouraged” by the decision.
Many drugs have been shown to have benefits beyond the purpose they are licensed for, but if their patent has expired, manufacturers have no commercial incentive to seek a new licence for this new purpose, meaning doctors are less likely to prescribe them.
The new measures, which will look at ways for these drugs to be prescribed on a more consistent basis, are contained in the Medical Treatments (Innovation) Bill – an altered version of the so-called Saatchi Bill, which aimed to make it easier for doctors to use experimental treatments.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments